minimal residual disease (mrd) in cll: is it clinically relevant?
Published 6 years ago • 1.7K plays • Length 21:09Download video MP4
Download video MP3
Similar videos
-
26:34
chronic lymphocytic leukemia: mrd updates
-
4:47
minimal residual disease in chronic lymphocytic leukemia
-
24:36
mrd in aml: what is it and what do i do about it?
-
22:56
measurable residual disease (mrd) in aml and all
-
19:41
multiple myeloma: minimal residual disease
-
1:18
what does minimal residual disease (mrd) mean for cll patients?
-
7:32
minimal residual disease in acute lymphoblastic leukemia
-
1:56:10
cancer treatment induced bone loss with dr. john neustadt
-
2:34
minimal residual disease (mrd): what does it mean for you?
-
1:35
mrd in cll: in which settings is its use most important?
-
56:04
minimal residual disease (mrd) overview | lrf ed forum series
-
21:08
mrd evaluation in myeloma: the future is here
-
19:40
mrd evaluation in myeloma: a necessary clinical tool?
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
24:17
combination of novel agents in cll: is this the final answer?
-
9:11
debate: should consolidation and minimal residual disease testing be used? - yes
-
20:43
venetoclax resistance: mechanisms and treatment options
-
1:09
why mrd is a hot topic in cll and how it should be used
-
4:47
how is minimal residual disease managed in patients with all?